Neuroprotective Properties
Another significant area of interest is the neuroprotective potential of this compound. Research indicates that certain pyrrolopyrimidine derivatives can protect neurons from oxidative stress and cell death, which are critical factors in neurodegenerative diseases like Alzheimer's and Parkinson's. By exploring this compound's ability to enhance neuronal survival and promote neurogenesis, it could contribute to new therapeutic strategies for managing chronic neurodegenerative conditions.
Anticancer Activity
The unique structure of N-methyl-N-[(3R,4R)-4-methylpiperidin-3-yl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine may also facilitate its investigation as an anticancer agent. Pyrrolopyrimidine compounds have shown promise in inhibiting key kinases involved in cancer cell proliferation. Therefore, this compound might be explored for its ability to selectively target cancer cells, offering a potential avenue for developing novel chemotherapeutic agents with improved efficacy and reduced side effects compared to conventional treatments.
Cognitive Enhancement
Research into cognitive enhancers has gained traction, and this compound holds promise as a potential cognitive enhancer or nootropic. By influencing synaptic plasticity and enhancing neurotransmitter release, N-methyl-N-[(3R,4R)-4-methylpiperidin-3-yl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine could help improve memory, learning, and overall cognitive performance, making it a candidate for treating age-related cognitive decline or cognitive deficits associated with various psychiatric disorders.
| Composition | C13H19N5 |
| Assay | 99 % |
| Appearance | Powder |
| CAS No. | 477600-74-1 |
| Packing | Drum |
| Shelf Life | 2 years |
| Storage | Store in cool and dry area |
| Certification | ISO. |